China’s Regulator Accepts Amgen’s Sotorasib for Breakthrough Therapy Designation as a First Milestone
Amgen, a leading global biotech company based in Southern California reported a first—the first time it has successfully achieved Breakthrough […]
Amgen, a leading global biotech company based in Southern California reported a first—the first time it has successfully achieved Breakthrough […]
Yuhan Corp reports that it made three poster presentations at the virtual meeting of the American Society of Clinical Oncology […]
Although Sanofi and Regeneron are not in the current PD-1/PD-L1 market mix they are scrambling to be with Libtayo (cemiplimab) […]
Medical research has established that a high Body Mass Index (BMI) adversely impacts one’s risk for obesity, diabetes, cardiovascular, and […]
Dr. Lyudmila Bazhenova, professor of Medicine and thoracic oncologist with the University of California San Diego, and active principal investigator in […]
Vaccitech Ltd announced today, December 18th, 2019, that its strategic collaboration with the Ludwig Institute for Cancer Research (Ludwig), Vaccitech Oncology […]
Clinical trials results have contributed to a new standard of care for lung cancer patients. The results from several of the […]
Patients with RET-fusion-positive non-small cell lung cancer (NSCLC) had a high response to LOXO-292 (selpercatinib), according to findings from the […]
In a Phase 1/2 trial MRTX849, an investigational KRAS G12C inhibitor has demonstrated clinical activity, including objective responses in patients […]
Suresh S. Ramalingam, MD, FASCO, Winship Canter Institute of Emery University, leads the discussion on the impact of overall survival […]